List All Merkel Cell Carcinoma Trials

Merkel Cell Carcinoma

 

Interleukin-12 by Electroporation for Merkel Cell Carcinoma
A Phase II Study of Intratumoral Injection of Interleukin-12 Plasmid and in Vivo Electroporation in Patients With Merkel Cell Carcinoma

Investigator: Shailender Bhatia, M.D.;   Conditions: Merkel Cell Carcinoma;    Status: Ongoing, Not Recruiting;   Study ID: NCT01440816

MSB0010718C for Metastatic Merkel Cell Carcinoma
A Phase II, Open-label, Multicenter Trial to Investigate the Clinical Activity and Safety of MSB0010718C in Subjects With Merkel Cell Carcinoma

Investigator: Shailender Bhatia, M.D.;   Conditions: Merkel Cell Carcinoma;    Status: Closed;   Study ID: NCT02155647

MK-3475 for Advanced Merkel Cell Carcinoma (8269a)
A Phase II Study of MK-3475 in Patients with Advanced Merkel Cell Carcinoma (MCC)

Investigator: Paul Nghiem;   Conditions: Recurrent Merkel Cell Carcinoma, Stage III Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT02267603

Neukoplast Infusions with Unresectable Stage III or Distant Metastatic Merkel Cell Carcinoma (20150886)
Phase II Study of Neukoplast (NK-92) Infusions in Patients with Unresectable Stage III (IIIB) or Distant Metastatic (IV) Merkel Cell Carcinoma (MCC)

Investigator: Shailender Bhatia, MD;   Conditions: Unresectable Stage III, Distant Metastatic Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT02465957

Polyclonal Autologous CD8 and Antigen-Specific T Cells for Metastatic Merkel Cell Carcinoma (9245)
Study to Evaluate Cellular Adoptive Immunotherapy Using Polyclonal Autologous CD8 + Antigen-Specific T Cells for Metastatic Merkel Cell Carcinoma in Combination with MHC Class I Up-regulation and the Anti-PD-L1 Antibody Avelumab

Investigator: Aude Chapuis, MD;   Conditions: Merkel Cell; Carcinoma;    Status: Recruiting;   Study ID: NCT02584829